IP Library Assignment 027662/0812
Patent Assignment
Reel/Frame 027662/0812

Assignment of Assignor's Interest

Recorded: 2012-02-07 Pages: 9
Assignor
DEFIANTE FARMACEUTICA, S.A.
Executed: 2012-02-03
Assignee
SIGMA-TAU RARE DISEASES, S.A.
RUA DOS FERREIROS, NO. 260, FUNCHAL, 9000-082, PORTUGAL
Covered Properties (16)
Microcrystals Comprising an Active Substance Having an Affinity for Phospholipids, and at Least One Phospholipid, Process of Preparation
Patent: 4,973,465 →
Application: 07/364,481 →
New Process for Preparing Lipid Microparticles
Patent: 5,100,591 →
Application: 07/582,053 →
Methods of Preparing Low-Toxicity Drug-Lipid Complexes
Patent: 6,406,713 →
Application: 08/430,661 →
Low Toxicity Drug-Lipid Systems
Patent: 5,616,334 →
Application: 08/430,699 →
Method of Treating CD4+ T Cell Lymphopenia in Immuno-Compromised Patients
Patent: 5,728,560 →
Application: 08/663,685 →
Composition and Methods for Treatment of Hiv Infection
Patent: 6,689,762 →
Application: 09/370,390 →
Recombinant Host for Producing L-Asparaginase Ii
Patent: 7,807,436 →
Application: 11/759,988 →
Publication: US 2008/0063632
Connector Enabling Multiple Sampling of Sealed Environment
Patent: 7,584,675 →
Application: 11/780,292 →
Publication: US 2009/0019954
Use of Adenosine Deaminase for Treating Pulmonary Disease
Application: 11/965,939 →
Publication: US 2008/0159964
Adenosine Deaminase Anticancer Therapy
Patent: 8,741,283 →
Application: 12/105,682 →
Publication: US 2009/0047270
Stable Recombinant Adenosine Deaminase
Patent: 8,071,741 →
Application: 12/105,913 →
Publication: US 2009/0047271
Recombinant Host for Producing L-Asparaginase Ii
Application: 12/773,320 →
Publication: US 2010/0273236
Recombinant host for producing L-asparaginase II
Application: 60/817,817 →
Adenosine Deaminase for Inhalation and Treatments Including the Same
Application: 60/882,748 →
Stable Recombinant Adenosine Deaminase
Application: 60/913,009 →
Enzymatic Anticancer Therapy
Application: 60/913,039 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest. Oct 31, 1990
From: LECLEF, BRIGITTE; CERFONTAINE, PATRICK; NICOLAS, JEAN-MARIE; WANTIER, HENRI
To: MEDGENIX GROUP S.A.
Reel/Frame 005501/0453 →
Assignment of Assignor's Interest May 12, 1994
From: CELLTARG S.A. (EX. IRE-CELLTARG S.A.)
To: LIPOSOME COMPANY, INC., THE
Reel/Frame 006984/0170 →
Assignment of Assignor's Interest May 12, 1994
From: MEDGENIX GROUP S.A.
To: LIPOSOME COMPANY, INC., THE
Reel/Frame 006983/0557 →
Assignment of Assignor's Interest Sep 23, 1996
From: SHORR, ROBERT G.L.
To: ENZON, INC.
Reel/Frame 008145/0133 →
Assignment of Assignor's Interest Sep 23, 1996
From: CLARK, MIKE A.
To: ENZON, INC.
Reel/Frame 008145/0135 →
Assignment of Assignor's Interest Nov 25, 1996
From: GODDARD, DAVID H.
To: ENZON, INC.
Reel/Frame 008244/0222 →
Merger Jun 14, 2002
From: LIPOSOME COMPANY, INC., THE
To: ELAN PHARMACEUTICALS, INC.
Reel/Frame 012958/0601 →
Assignment of Assignor's Interest Feb 12, 2003
From: ELAN PHARMACEUTICALS, INC.
To: ENZON, INC.
Reel/Frame 013746/0545 →
Change of Name Feb 13, 2003
From: RHONE-POULENC RORER PHARMACEUTICALS INC.
To: AVENTIS PHARMACEUTICALS PRODUCTS INC.
Reel/Frame 013430/0123 →
Change of Name Feb 13, 2003
From: AVENTIS PHARMACEUTICALS PRODUCTS INC.
To: AVENTIS PHARMACEUTICALS INC.
Reel/Frame 013428/0871 →
Assignment of Assignor's Interest Mar 7, 2003
From: AVENTIS PHARMACEUTICALS, INC.
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 013471/0644 →
Assignment of Assignor's Interest Jun 5, 2003
From: AVRAMIS, VASSILIOS; COHEN, LEWIS
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 014145/0104 →
Assignment of Assignor's Interest Sep 19, 2006
From: FILPULA, DAVID RAY; WANG, MAOLIANG
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 018272/0792 →
Corrective Assignment to Correct the 1) Postal Code of Assignee Previously Recorded on Reel 018272 Frame 0792. Assignor(S) Hereby Confirms the 1) Postal Code of Assignee Is "08807" Not "10016". Sep 25, 2006
From: FILPULA, DAVID RAY; WANG, MAOLIANG
To: ENZON PHARMACEUTICALS, INC
Reel/Frame 018299/0089 →
Assignment of Assignor's Interest Jun 26, 2007
From: FILPULA, DAVID RAY; WANG, MAOLIANG
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 019479/0476 →
Assignment of Assignor's Interest Jul 19, 2007
From: EVANS, ROY L.
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 019577/0781 →
Assignment of Assignor's Interest Jan 17, 2008
From: HORAK, IVAN; SAPRA, PUJA
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 020376/0314 →
Assignment of Assignor's Interest Jan 17, 2008
From: BLACKBURN, MICHAEL R.
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 020378/0656 →
Assignment of Assignor's Interest Apr 24, 2008
From: KELLEMS, RODNEY E.
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 020850/0268 →
Assignment of Assignor's Interest Jun 13, 2008
From: FILPULA, DAVID R; SAPRA, PUJA
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 021093/0804 →
Assignment of Assignor's Interest Jun 16, 2008
From: FILPULA, DAVID R.; YOUNGSTER, STEPHEN K.
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 021099/0336 →
Executive Order 9424, Confirmatory License Feb 4, 2009
From: UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022204/0113 →
Confirmatory License Nov 3, 2009
From: UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023460/0093 →
Assignment of Assignor's Interest Feb 16, 2010
From: ENZON PHARMACEUTICALS, INC.
To: DEFIANTE FARMACEUTICA, S.A.
Reel/Frame 023937/0530 →
Change of Name Feb 16, 2010
From: ENZON, INC.
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 023937/0543 →